Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
OPERATING EXPENSES:
Amortization	$ 57,344	$ 57,344	$ 172,032	$ 172,032
Research and development expenses	3,577,142	789,577	11,385,586	2,019,557
Selling, general and administrative expenses	2,114,348	2,154,590	6,403,508	4,260,042
TOTAL OPERATING EXPENSES	5,748,834	3,001,511	17,961,126	6,451,631
LOSS FROM OPERATIONS	(5,748,834)	(3,001,511)	(17,961,126)	(6,451,631)
OTHER (INCOME) EXPENSE:
Change in fair value of derivative liabilities	386,450		(1,168,804)	(8,279,919)
Interest expense	918,633		1,236,010	559,455
Interest income	(13,273)	(8,643)	(32,621)	(14,408)
TOTAL OTHER EXPENSE (INCOME), NET	1,291,810	(8,643)	34,585	(7,734,872)
NET (LOSS)/INCOME	(7,040,644)	(2,992,868)	(17,995,711)	1,283,241
Deemed dividends - related party				53,598,320
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	$ (7,040,644)	$ (2,992,868)	$ (17,995,711)	$ (52,315,079)
NET LOSS PER COMMON SHARE
- Basic	$ (0.28)	$ (0.22)	$ (0.73)	$ (4.64)
- Diluted	$ (0.28)	$ (0.22)	$ (0.73)	$ (4.64)
WEIGHTED AVERAGE NUMBER OF COMMON  SHARES OUTSTANDING
- Basic	24,984,083	13,919,933	24,555,382	11,269,212
- Diluted	24,984,083	13,919,933	24,555,382	11,269,212